These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27040868)

  • 1. CRISPR: express delivery to any DNA address.
    Peterson A
    Oral Dis; 2017 Jan; 23(1):5-11. PubMed ID: 27040868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking CRISPR's Footprints.
    Lin L; Luo Y
    Methods Mol Biol; 2019; 1961():13-28. PubMed ID: 30912037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 4. Strong association between genomic 3D structure and CRISPR cleavage efficiency.
    Bergman S; Tuller T
    PLoS Comput Biol; 2024 Jun; 20(6):e1012214. PubMed ID: 38848440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR's Path to the Clinic.
    Miccio A
    CRISPR J; 2022 Feb; 5(1):2-3. PubMed ID: 35191749
    [No Abstract]   [Full Text] [Related]  

  • 6. How Scientists Perceive CRISPR's Translational Promise and the Implications for Individuals with Genetic Conditions.
    Halpern J; O'Hara SE; Owen AL; Paolo D
    Ethics Hum Res; 2021 Nov; 43(6):28-41. PubMed ID: 34751516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Based Tools in Immunity.
    Simeonov DR; Marson A
    Annu Rev Immunol; 2019 Apr; 37():571-597. PubMed ID: 30698999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR Craft: DNA Editing the Reconstructive Ladder.
    Roh DS; Li EB; Liao EC
    Plast Reconstr Surg; 2018 Nov; 142(5):1355-1364. PubMed ID: 30511992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR editing in biological and biomedical investigation.
    Huang J; Wang Y; Zhao J
    J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edited course of biomedical research: leaping forward with CRISPR.
    Collins PJ; Hale CM; Xu H
    Pharmacol Res; 2017 Nov; 125(Pt B):258-265. PubMed ID: 28918173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
    Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
    Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome "Surgery"?
    Klein M
    Hastings Cent Rep; 2018 Mar; 48(2):inside front cover. PubMed ID: 29590513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CRISPR/Cas: technique to repair DNA errors: is a clinical breakthrough near?].
    van de Vrugt HJ; Cornel MC; Wolthuis RMF
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
    Luo J
    Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
    Kofler N; Kraschel KL
    Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.